Paper25978366
Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancer.
Ascolani G and 2 others. PLoS Comput Biol, 2015. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancer. Papers, record 25978366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25978366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancer.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoma, Ductal, Breast | Major topic |
| Models, Biological | Major topic |
| Neoplastic Cells, Circulating | Major topic |
| Biomarkers, Tumor | |
| Computer Simulation | |
| Disease Progression | |
| Female | |
| Gene Expression Profiling | |
| Humans | |
| Kaplan-Meier Estimate | |
| Survival Rate | |
| Transforming Growth Factor beta |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11961144 | Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. | Mol Pharmacol | 2002 | https://conductscience.org/library/papers/11961144 | PubMed |
| 2 | 24519765 | Too much mammography. | BMJ | 2014 | https://conductscience.org/library/papers/24519765 | PubMed |
| 3 | 9169439 | Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9169439 | PubMed |
| 4 | 23918358 | Experiments on the role of deleterious mutations as stepping stones in adaptive evolution. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23918358 | PubMed |
| 5 | 17365852 | Platelets possess functional TGF-beta receptors and Smad2 protein. | Platelets | 2007 | https://conductscience.org/library/papers/17365852 | PubMed |
| 6 | 22837985 | Adhesion receptors as therapeutic targets for circulating tumor cells. | Front Oncol | 2012 | https://conductscience.org/library/papers/22837985 | PubMed |
| 7 | 24599057 | Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer. | PLoS One | 2014 | https://conductscience.org/library/papers/24599057 | PubMed |
| 8 | 19589136 | Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. | Breast Cancer Res | 2009 | https://conductscience.org/library/papers/19589136 | PubMed |
| 9 | 24687923 | Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24687923 | PubMed |
| 10 | 24824552 | Bisphosphonates in breast cancer. | Int J Cancer | 2015 | https://conductscience.org/library/papers/24824552 | PubMed |
| 11 | 25171411 | Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. | Cell | 2014 | https://conductscience.org/library/papers/25171411 | PubMed |
| 12 | 18175071 | The Met tyrosine kinase receptor in development and cancer. | Cancer Metastasis Rev | 2008 | https://conductscience.org/library/papers/18175071 | PubMed |
| 13 | 25108081 | Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study). | Bone | 2014 | https://conductscience.org/library/papers/25108081 | PubMed |
| 14 | 24586338 | Modeling TGF-β in early stages of cancer tissue dynamics. | PLoS One | 2014 | https://conductscience.org/library/papers/24586338 | PubMed |
| 15 | 12742232 | Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway. | Cell Signal | 2003 | https://conductscience.org/library/papers/12742232 | PubMed |
| 16 | 19584232 | Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. | Mol Cancer Ther | 2009 | https://conductscience.org/library/papers/19584232 | PubMed |
| 17 | 10856220 | Role of CD47 as a marker of self on red blood cells. | Science | 2000 | https://conductscience.org/library/papers/10856220 | PubMed |
| 18 | 21611158 | Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. | PLoS One | 2011 | https://conductscience.org/library/papers/21611158 | PubMed |
| 19 | 19487818 | The basics of epithelial-mesenchymal transition. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19487818 | PubMed |
| 20 | 9548474 | T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4. | J Immunol | 1997 | https://conductscience.org/library/papers/9548474 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36227551 | Machine Learning Methods for Survival Analysis with Clinical and Transcriptomics Data of Breast Cancer. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36227551 | PubMed |
| 33674749 | Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance. | Oncogene | 2021 | https://conductscience.org/library/papers/33674749 | PubMed |
| 32258970 | Modeling the Human Bone-Tumor Niche: Reducing and Replacing the Need for Animal Data. | JBMR Plus | 2020 | https://conductscience.org/library/papers/32258970 | PubMed |
| 31345216 | Modeling breast cancer progression to bone: how driver mutation order and metabolism matter. | BMC Med Genomics | 2019 | https://conductscience.org/library/papers/31345216 | PubMed |
| 29207686 | Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/29207686 | PubMed |
| 27084578 | Signatures of breast cancer metastasis at a glance. | J Cell Sci | 2016 | https://conductscience.org/library/papers/27084578 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| CD47 | 961 | PubTator's text mining | https://conductscience.org/library/genes/961 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| EPCAM | 4072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| GEN1 | 348654 | PubTator's text mining | https://conductscience.org/library/genes/348654 | NCBI Gene |
| MET | 4233 | PubTator's text mining | https://conductscience.org/library/genes/4233 | NCBI Gene |
| PTHLH | 5744 | PubTator's text mining | https://conductscience.org/library/genes/5744 | NCBI Gene |
| SLTM | 79811 | PubTator's text mining | https://conductscience.org/library/genes/79811 | NCBI Gene |
| SUGP1 | 57794 | PubTator's text mining | https://conductscience.org/library/genes/57794 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25978366
GET https://conductscience.org/api/papers/v1/25978366/references?page=2